Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire4 November 2025
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
BOSTON and ROLLE, Switzerland, Nov. 4, 2025 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today…
Read More » -
Cision PR Newswire4 November 2025
Sealed Air Reports Q3 2025 Results
Third Quarter 2025 Highlights and Financial Results Net Earnings and EPS improvement resulting from improved operating leverage and favorable resolution…
Read More » -
Cision PR Newswire4 November 2025
AI in Edge Computing Market to Surpass USD 83.86 Billion by 2032, Driven by Industrial IoT, 5G, and Intelligent Infrastructure Expansion | DataM Intelligence
AUSTIN, Texas and TOKYO, Nov. 4, 2025 /PRNewswire/ — According to DataM Intelligence, the AI in Edge Computing Market Size is witnessing…
Read More » -
Business Wire4 November 2025
Dubai Holding and Palantir launch Aither: A joint venture to lead AI transformation
Aither, Palantir’s first joint venture in the UAE, will drive AI-powered transformation across Dubai’s public and private sectors As the…
Read More » -
Business Wire4 November 2025
Global Payments Reports Third Quarter 2025 Results
Third quarter 2025 GAAP diluted earnings per share (EPS) of $2.64 and adjusted EPS of $3.26, an increase of 11%…
Read More » -
Business Wire4 November 2025
Uber Announces Results for Third Quarter 2025
Trips grew 22% year-over-year and Gross Bookings grew 21% year-over-year Income from operations of $1.1 billion; Adjusted EBITDA of $2.3…
Read More » -
Business Wire4 November 2025
PJT Partners Inc. Reports Record Third Quarter and Nine Months 2025 Results
Third Quarter Overview Record Third Quarter Revenues, Pretax Income and EPS Revenues of $447 million, an increase of 37% from…
Read More » -
Business Wire4 November 2025
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
Strategic financing to advance development of sac-TMT while Merck continues to progress its broad and expansive pipeline RAHWAY, N.J.–(BUSINESS WIRE)–Merck…
Read More » -
Business Wire4 November 2025
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the company,…
Read More » -
Business Wire4 November 2025
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
Focused Execution Delivers Strong EPS Performance Landmark Agreement Reached with U.S. Government Provides Longer-Term Business Clarity Secured Early FTC Clearance…
Read More »


